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C/ebpaAbstract The objectives of this study were to explore the effect of COST (one thousand Da
molecular weight chitosan oligosaccharide) on the differentiation of 3T3-L1 preadipocytes and to
determine the mechanism of action. 3T3-L1 preadipocytes were used as the target cells, and the
induction of the methods for the differentiation of 3T3-L1 preadipocytes was based on classic cock-
tails. The MTT assay was used to filtrate the concentration of COST. On the 6th day of induced-
differentiation, the differentiation of 3T3-L1 cells was detected by Oil Red O staining. The expres-
sion of PPARc and C/EBPa mRNA was determined using real-time fluorescence quantitative PCR
(Q-PCR). COST inhibited 3T3-L1 preadipocyte differentiation in a dose-dependent manner and
decreased lipid accumulation. At the molecular level, the expression of the transcription factors,
PPARc and C/EBPa, was reduced by COST during adipogenesis. These results indicate that COST
effectively inhibited the differentiation of 3T3-L1 preadipocytes. The mechanism is related to the
down-regulation expression of PPARc and C/EBPa.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Along with economic development, the incidence of obesity is
increasing rapidly. Obesity features excessive fat accumulation
and storage due to an imbalance between energy intake and
energy expenditure (Chen et al., 2013). Obesity is also a
chronic metabolic disease that increases the risk of a number
of diseases (Oliveros et al., 2014), such as type 2 diabetes,
hypertension and atherosclerosis (Corvera and Gealekman,
2014). Furthermore, several studies suggest that obesity is
associated with the development of cancer (McDonnell et al.,
252 S. Kong et al.2014). The metabolism of adipose tissue plays an important
role in obesity. White adipose tissue and brown adipose tissue
are two distinct adipose tissues in mammals, including adult
humans. The function of white adipose tissue is to store excess
energy when nutrient intake exceeds energy expenditure (Bi
and Li, 2013). By contrast, brown adipose tissue is involved
in energy dissipation to produce heat through non-shivering
thermogenesis. Cold exposure and treatment with
b3-adrenergic agonists enhance brown adipose tissue activity
and promote white adipose tissue browning (Palou et al.,
2013). Therefore, turning white fat into brown fat has become
a new strategy for the prevention and management of obesity
and related diseases.
Currently, the modes of action of diet pills include blocking
the intestinal digestion of fat; targeting the neurotransmission
of norepinephrine, dopamine and serotonin; and inhibiting the
endocannabinoid system (Carter et al., 2012). Different
degrees of side effects exist for many anti-obesity medications.
Orlistat is a lipase inhibitor that reduces the intestinal absorp-
tion of fat and is widely used in anti-obesity treatment. How-
ever, orlistat can cause fecal incontinence, reduce the
absorption of fat-soluble vitamins and cause liver damage
(Hada et al., 2015). Some anti-obesity drugs have been
removed from the market because of their serious side effects.
3T3-L1 preadipocytes differentiate into mature adipocytes
in vitro. The 3T3-L1 cell line is widely used as an adipocyte dif-
ferentiation model system for studying the metabolic mecha-
nisms of obesity and the molecular mechanisms of
adipogenesis (Boschi et al., 2014). Adipokines are a type of
bioactive polypeptide and include leptin, adiponectin and
tumor necrosis factor-alpha, which are released from adipo-
cytes. These peptides play a vital role in regulating appetite
and energy expenditure and are necessary for modulating insu-
lin sAlong with economic development, the incidence of obe-
sity is increasing insulin sensitivity and fat metabolism (Kang
et al., 2016). Obesity is often accompanied by adipocyte hyper-
plasia or hypertrophy and excessive lipid storage in adipose tis-
sue (Kim et al., 2014). Therefore, the regulation of
preadipocyte differentiation or the inhibition adipogenesis
may provide an effective mechanism to prevent obesity and
obesity-related diseases.
During differentiation, the peroxisome proliferator-
activated receptor-c (PPARc) and CCAAT/enhancer binding
protein-a (C/EBPa) are two key transcription factors (Zhang
et al., 2014). PPARc, a sub-family of nuclear hormone recep-
tors, activates the gene expression of fatty acid-binding protein
and phosphoenolpyruvate carboxykinase to promote lipid syn-
thesis. C/EBPa proteins play a crucial role during the matura-
tion and differentiation of adipocytes. The expression of C/
EBPa generates a coordinated effect with PPARc to induce
adipogenesis (Liss et al., 2014). In this study, we elucidated
the mechanism and effects of COST on adipocyte
differentiation.
COST, the chitosan depolymerization product, is a b-1,4
glycosidic linked glucosamine, with good solubility in water.
It is nontoxic and is more easily degraded and absorbed com-
pared to chitosan (Liu et al., 2013). Chitosan has been widely
used in pharmaceutics. In our previous studies, we showed that
nano-particle systems made from chitosan were efficient carri-
ers for the transport of insulin through the nasal mucosa (Su
et al., 2010). However, chitosan has high viscosity and is
insoluble in water, but it is soluble in acidic solutions. Theseproperties of chitosan limit its application as a biodegradable
and biocompatible biopolymer in the pharmaceutical and
biotechnological industries. Therefore, water-soluble chitosan
is attractive because of its lower viscosity and solubility in
water. Recently, a study on water-soluble chitosan microparti-
cles loaded with insulin supported the hypothesis that insulin-
loaded water-soluble chitosan microparticles are promising
oral vehicle systems for insulin. In addition, several reports
indicated that water-soluble chitosan microspheres reduced
blood lipids and plasma viscosity in rats fed high-fat diets
(Tao et al., 2013). This suggests that water-soluble chitosan
microspheres are effective in improving hyperlipidemia. Simul-
taneously, nanoparticles composed of water-soluble chitosan
were prepared, and the results of the in vitro studies indicated
that the water-soluble chitosan nanoparticles could be used as
a carrier system for protein drugs. Moreover, water-soluble
chitosan nanoparticles are efficient at inhibiting hypercholes-
terolemia in rats fed high-fat diets. More intriguingly, COST
possesses promising biological effects, including antidiabetic,
antioxidant, anti-obesity and anti-inflammation activities
(Fang et al., 2014). Therefore, studies focused on the applica-
tion of COST in medicine have attracted great interest from
researchers.
Our team has confirmed that the COST has high activity of
anti-obesity, and can prevent hyperlipidemia and nonalcoholic
fatty liver induced by high fat diet in SD rats. In the present
study, different concentrations of COST were evaluated for
their effects on lipogenesis in 3T3-L1 cells. Additionally, the
possible mechanisms for this effect are discussed, focusing on
the expression of adipogenic transcription factors, such as
PPARc and C/EBPa.
2. Material and methods
2.1. Materials
3T3-L1 fibroblasts were purchased from the Chinese Academy
of Sciences cell bank. COST was obtained from Shandong
Laizhou Haili Biological Products Co, Ltd. Dulbecco’s modi-
fied Eagle’s medium (DMEM), bovine calf serum (BCS) and
Oil Red O were purchased from GIBCO (Burlington, ON,
Canada). Fetal bovine serum (FBS) and penicillin-
streptomycin were purchased from Hyclone (USA).
Dexamethasone (DEX), dimethylsulfoxide (DMSO),
1-methyl-3-isobutylxanthine (IBMX), 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) and insulin were
purchased from Sigma–Aldrich (USA). RNAiso Reagent,
cDNA synthesis Kit and RT-PCR Kit were purchased from
Toyo Spinning (Shanghai) Biotechnology Limited. All other
chemicals and solvents were of analytical grade.
2.2. 3T3-L1 cell culture and differentiation
3T3-L1 preadipocytes were cultured at 37 C and 5% CO2
with Dulbecco’s modified Eagle’s medium (DMEM) contain-
ing 10% (v/v) bovine calf serum (BCS) and 1% penicillin-
streptomycin. After reaching 80–90% confluence, the 3T3-L1
cells were subcultured. First, the cells were flushed with a
0.25% (w/v) pancreatic enzyme solution to remove serum con-
taining trypsin inhibitor. Then, the cells were treated with a
trypsin-EDTA solution. For adipocyte differentiation, the
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3  103 cell/cm2 to confluence. At 80% confluence, the cells
were differentiated with 10 lg mL1 insulin, 1 lM dexametha-
sone and 0.5 mM IBMX in DMEM containing 10% (v/v) fetal
bovine serum (FBS) and 1% penicillin-streptomycin. On day 2
of differentiation, the cells were treated with 1 lg mL1 insulin
in DMEM with 10% (v/v) fetal bovine serum (FBS) and 1%
penicillin-streptomycin. The culture medium was changed
every 2 days for 15 days.2.3. MTT assay
Cell viability was assessed using the MTT assay. 3T3-L1 prea-
dipocytes were plated into 96-well plates at a density of
3  104 cells per well in a 100-ll cell suspension and cultured
in DMEM containing 10% BCS for 24 h. The cells were then
treated with 0, 1, 10, 50, 100 and 1000 lg mL1 COST for 24 h.
After 24 h, the MTT (20 l1, 5 mg mL1) solution was added to
each well and the cells were incubated at 37 C for 4 h. The
medium was then removed and the insoluble formazan crystals
were dissolved in DMSO (100 ll/well). The absorbance at
485 nm was measured using a microplate spectrophotometer
(Mithras LB-940, Berthold, Germany).2.4. Determination of lipid accumulation by Oil Red O staining
COST at a concentrations of 1, 10 and 100 lg mL1 was added
to the DMEM with 10% FBS at each of the three stages of adi-
pocyte differentiation. After differentiation, the cells were
washed twice with phosphate-buffered saline (PBS,
pH = 7.4) and fixed with formaldehyde (4%, 2 ml) for 1 h at
room temperature. After washing with distilled water three
times, the cells were then stained with 1.2 mg mL1 Oil Red
O dye/60% isopropanol solution for 1 h. Excess Oil Red O
dye was washed away with distilled water. The images of the
Oil Red O stained cells were acquired using an inverted con-
trast phase microscope (Axiovert 40 CFL, Carl Zeiss, Jena,
Germany).2.5. RNA isolation and real-time quantitative PCR
On day 2 of differentiation, total RNA from 3T3-L1 cells was
extracted with Trizol Reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer’s protocol. First-strand cDNA
synthesis was performed with 1 lg of total RNA using a Tran-
Scriba Kit (A&A Biotechnology, Poland). Quantification of
gene expression in the 3T3-L1 cells treated with COST was
measured using a real-time PCR system (SmartCycler DX
real-time PCR System Cepheid, USA). PCR was performed
in a final volume of 20 ll, including 10 ng of sample cDNA,
5 lM of specific forward and reverse primers, and 15 ll of Real
Time 2xPCR Master Mix EvaGreen. The reaction mixtures
were incubated for an initial denaturation at 93 C for 3 min,
followed by 45 PCR cycles of 1 min at 93 C, 1 min at 60 C





CAAAGCCCAGAAACCTA-30. The relative amount of each
gene was calculated using the 2DDCt method.
2.6. Statistical analysis
The data were expressed as mean ± SD. Unpaired Student’s t-
tests were used when appropriate to evaluate the differences
between the two group means. Differences between the mean
values of multiple groups were analyzed by one-way analysis
of variance. Values of P< 0.05 were considered statistically
significance.
3. Results
3.1. Induced-differentiation of 3T3-L1 preadipocytes
Lipid droplets in cells stained with Oil Red O before inducing
differentiation are tiny and spindly (Fig. 1A). On day 6 of dif-
ferentiation, the cells grew round and ring lipid droplets
emerged (Fig. 1B). On the 14th day, the intracellular lipid dro-
plets were plump and full and the 3T3-L1 preadipocytes differ-
entiated into mature fat cells (Fig. 1C) (see Fig. 2).
COST at concentrations of 1, 10, 100, 500 and
1000 lg mL1 were used to filtrate concentrations of COST.
COST at doses of 1, 10, 100, 500 and 1000 lg mL1 reduced
the viability of preadipocytes by 2.05%, 7.40%, 8.54%,
11.1% and 11.8%, respectively, compared to the control adi-
pocytes not treated with COST (Table 1).
3.2. Effect of COST on the expression of PPAR c and C/EBPa
To determine the potential intracellular mechanisms regulating
the differentiation of 3T3-L1 preadipocytes, the expression of
PPARc and C/EBPa as necessary transcription factors during
differentiation was monitored using quantitative real-time
PCR. The expression levels of PPARc and C/EBPa were mea-
sured after the differentiation-inducing process for 3T3-L1
cells exposed to COST at concentrations of 1, 10 and
100 lg mL1. The results showed that COST suppressed the
expression of PPARc and C/EBPa compared to the model adi-
pocytes not treated with COST (Fig. 3). The inhibitory effect
of COST on the expression of PPARc mRNA and C/EBPa
mRNA was dose-dependent.
Obesity is a serious global health problem that is associated
with high morbidity and mortality. In the present study, 1, 10
and 100 lg mL1 concentrations of COST suppressed lipid
accumulation during differentiation. Differentiation of
3T3-L1 preadipocytes and adipogenesis is a dynamic and
sophisticated process regulated by hormones, genes and signal
transduction pathways. In this study, Q-PCR showed that
COST downregulated the key adipogenic genes PPARc and
C/EBPa in a dose-dependent manner. The S100A16 protein
is ubiquitously expressed, and S100A16 stimulates adipogene-
sis by increasing PPARc promoter luciferase activity during
lipogenesis (Li et al., 2013).
Fat cells are sensitive to insulin, and the decreased sensitiv-
ity of adipocytes to insulin plays a critical role in the develop-
ment of type 2 diabetes. Sterol regulatory element binding
Figue 1 A: 0 day, B: 6 day, C: 14 day. Intracellular lipid
accumulation during differentiation stained with Oil Red O, the
results showed more and more fat droplets accumulation.
Figure 2 A: control, B: model, C: 1 lg mL1, D: 10 lg mL1, E:
100 lg mL1. Effect of different COST concentrations on the
accumulation of lipids in adipocytes. Control 3T3-L1 cells were
differentiated in the absence of a differentiation inducer. During
the induction of differentiation, the cells were treated with COST
at concentrations of 1, 10 and 100 lg mL1, except for the model
adipocytes not exposed to COST, different concentrations COST
suppressed fat accumulation of adipose cells was observed in this
figure.
Figure 3 Effect of COST on the expression of PPARc and C/
EBPa. During differentiation, 3T3-L1 cells were exposed to COST
at concentrations of 1, 10 and 100 lg mL1, except for the model
adipocytes not exposed to COST. Control adipocytes were not
treated with a differentiation inducer. The results showed COST
effectively inhibited the expression of PPARc and C/EBPa. Data
are given as mean value ± SD (n= 3), **p< 0.01 compared to
the model.
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ulating the synthesis of cholesterol, fatty acids and triglycerides
(Shao and Espenshade, 2014). Activation of the SREBP-1c sig-
naling pathway promotes the synthesis of liver fat and the
release of triglycerides (Lucero et al., 2015). Accumulating evi-
dence indicates that COST has beneficial lipid-regulating
effects, including decreasing plasma very-low-density lipopro-
tein triglyceride and increasing high-density lipoprotein choles-Table 1 Effects of COST on the viability of 3T3-L1 cells (mean ±
C (lg mL1) 1 10 100
A490nm 0.631 ± 0.014 0.602 ± 0.026 0.595 ± 0
Survival (%) 97.13 91.88 90.63terol in animal models (Wang et al., 2011). This suggests that
the lipid-regulating activity of COST may be associated with
the expression of SREBP, PPAR and C/EBP. Cold exposure
or treatment with norepinephrine can stimulate heat produc-
tion as a result of increased uncoupling protein 1 (UCP1)
expression (Shore et al., 2013). Therefore, mitochondria are
the primary source of energy production via aerobic respira-
tion in cells. Recent studies suggest that obesity is associated
with mitochondrial dysfunction, decreased oxygen consump-
tion rates and citrate synthase activity, which contribute to
the compromised oxidative capacity of mitochondria in adipo-
cytes from obese humans (Shore et al., 2013). This suggests
that the weight-loss effects of COST may be associated with
increased adipocyte mitochondrial function.SD, n= 6).
500 1000 0
.027 0.581 ± 0.042 0.578 ± 0.019 0.099 ± 0.016
88.12 87.43 1
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In summary, our results suggest that COST suppresses lipid
accumulation during differentiation by down-regulating the
adipogenesis-related transcription factors PPARc and
C/EBPa. Glucosamine is the unit of COST, and interestingly,
COST with different degrees of polymerization (DP), such as
dimers, trimers, tetramers, and pentamers, have a high biolog-
ical activity. Further research will focus on techniques to sep-
arate COST and obtain COST with a specific DP. To study the
molecular mechanisms in greater detail, additional studies are
required to determine the mechanism by which COST with a
specific DP influences the expression of PPARc and C/EBPa
and whether any other pathways are involved in adipogenesis
using animal models. Obesity is the risk factor of hyperlipi-
demia, nonalcoholic fatty liver and Type two diabetes mellitus;
excessive fat accumulation is an important factor of obesity,
the results from the present study identify the anti-obesity
and lipid-regulating properties of COST, and the development
of COST may be a promising agent for preventing obesity and
obesity-related diseases.
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